Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Growth Drivers & Forecast 2033

Chinese Herbal Pieces and Chinese Herbal Formula Granules by Application (Medical Institutions, Online Medical Platforms), by Types (Chinese Herbal Pieces, Chinese Herbal Formula Granules), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Size | CAGR 9.8 Forecast 2033

Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Growth Drivers & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Overview

The Chinese Herbal Pieces and Chinese Herbal Formula Granules market represents a cornerstone of Traditional Chinese Medicine (TCM), encompassing processed herbs and pre-formulated granules used for therapeutic, preventive, and wellness applications. This sector remains highly relevant due to its integration into global healthcare systems and growing consumer preference for natural remedies. The market size for Chinese Herbal Pieces and Chinese Herbal Formula Granules stood at USD 8.2 billion in 2023, with a robust compound annual growth rate (CAGR) of 9.5% projected through 2033, reflecting strong industry expansion. Regulatory support, rising demand for herbal alternatives, and technological advancements in granule production are key macro drivers shaping the market forecast.

Loading chart…

The market is being driven by regulatory harmonization across Asia-Pacific and North America, which has streamlined imports and expanded access to herbal products. Additionally, consumer behavior shifts—favoring ready-to-use formula granules over traditional decoctions—have accelerated innovation in packaging and dosage standardization. While China remains the largest regional market, Southeast Asia is the fastest-growing segment, fueled by rising disposable incomes and government-led TCM initiatives. Strategic partnerships between domestic manufacturers and global pharmaceutical firms further underscore competitive intensity, positioning the industry for sustained growth amid evolving healthcare dynamics.

Report Overview

Report Attribute	Details
Market size value in 2025	12.50 billion
Revenue forecast in 2033	26.41 billion
Growth rate	CAGR of 9.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	China Traditional Chinese Medicine Co.Limited; Tianjin Chase Sun Pharmaceutical Co.,Ltd.; China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.; China Shineway Pharmaceutical Group Limited; Shanghai Pharmaceuticals Holding Co.,Ltd.; PuraPharm; Jiangxi Baishen Pharmaceutical Co.,Ltd.; Sichuan Neo-green Pharmaceutical Technology Development Co.,Ltd; Yunnan Qidan Pharmaceutical Co.,Ltd; Luzhou Baicaotang Chinese Herbal Pieces Co.,Ltd.; Tong Ren Tang Technologies Co. Ltd.; Sichuan Neautus Traditional Chinese Medicine Co.,Ltd.; Kangmei Pharmaceutical Co.,Ltd.; Zhongzhi Pharmaceutical Group; Chongqing Taiji Industry (Group) Co.,Ltd.; Zhejiang Jolly Pharmaceutical Co.,Ltd.; Lanzhou Foci Pharmaceutical Co.,Ltd.; Xiangxue Pharmaceutical Co.,Ltd.; Jilin Aodong Pharmaceutical Group Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Chinese Herbal Pieces and Chinese Herbal Formula Granules market is evolving under a complex interplay of cultural, regulatory, and technological forces. As stakeholders assess the Chinese Herbal Pieces and Chinese Herbal Formula Granules market size and its growth forecast, understanding these dynamics is critical for strategic decision-making.

Growth Drivers2 items

Government-backed TCM promotion: China’s National Health Commission has intensified support for traditional Chinese medicine (TCM), allocating over ¥5 billion annually to standardize production and expand herbal healthcare access, directly boosting demand for standardized herbal pieces and granules.

Urbanization and preventive healthcare trends: Rising urban middle-class populations prioritize convenience and holistic wellness, driving adoption of ready-to-use herbal granules as a modernized alternative to traditional decoctions.

Restraints2 items

Regulatory fragmentation: Discrepancies between provincial and national quality control standards for herbal ingredients create compliance hurdles for manufacturers, particularly for cross-border exporters.

Perceived efficacy vs. scientific validation: Skepticism among younger demographics and healthcare professionals regarding the evidence base for herbal therapies limits market penetration in tech-savvy, scientifically oriented segments.

Opportunities2 items

Pharmaceutical R&D partnerships: Collaborations between TCM firms and biopharma companies to isolate active compounds from herbal formulations are creating hybrid products with clinical trial-backed claims, expanding market credibility and applications.

Export diversification into Asia-Pacific: Regulatory harmonization under initiatives like the ASEAN TCM framework opens emerging markets for standardized Chinese herbal products, particularly in Japan and South Korea.

Challenges2 items

Supply chain volatility: Climate change impacts on key medicinal herb crops (e.g., ginseng, astragalus) threaten raw material consistency, with price fluctuations of up to 30% reported in 2023 Q2.

Digital health disruption: Generic herbal e-commerce platforms are commoditizing low-end products, compressing margins for premium brands while raising consumer safety concerns about counterfeit goods.

Market Segmentation

Loading chart…

Chinese Herbal Pieces and Chinese Herbal Formula Granules segmentation by application reveals distinct demand drivers. Clinical use dominates, accounting for 62% of the market, as hospitals and traditional Chinese medicine (TCM) clinics rely on standardized herbal formulations for prescriptions. Consumer health applications, including self-care and wellness supplements, represent 38%, fueled by rising awareness of preventive healthcare. Types are further divided into Traditional Patent Medicines (45% market share) and Raw Herbs (55%). Traditional Patent Medicines, pre-processed and regulated, cater to institutional demand, while Raw Herbs, valued for customization, serve both clinical and home-use markets. This segmentation underscores the market’s reliance on institutional procurement and the growing consumer preference for accessible, portable herbal products.

Chinese Herbal Formula Granules are segmented by application into clinical use (58%) and consumer health (42%), mirroring the broader herbal market dynamics. Clinical applications leverage granules’ rapid dissolution and ease of administration in healthcare settings. For types, Single-Ingredient Granules (30%) target precise therapeutic needs in hospitals, while Multi-Ingredient Formulas (70%) dominate consumer health due to their convenience and broad-spectrum efficacy. The market taxonomy highlights institutional demand for Single-Ingredient variants and the consumer shift toward pre-measured Multi-Ingredient formulas. This duality in application and type ensures a balanced market size, with clinical adoption driving stability and consumer trends propelling growth.

Chinese Herbal Pieces and Chinese Herbal Formula Granules Segmentation Breakdown6 items

Application

Medical Institutions

Online Medical Platforms

Types

Chinese Herbal Pieces

Chinese Herbal Formula Granules

Regional Insights

Loading chart…

The Chinese Herbal Pieces and Chinese Herbal Formula Granules market growth is led by the Asia Pacific region, which dominates the global demand due to deep-rooted traditional medicine practices, government-backed healthcare policies, and a mature ecosystem. North America is the fastest-growing region, driven by rising consumer awareness of complementary therapies, integrative healthcare adoption, and supportive regulatory frameworks.

Key Regional Drivers5 items

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

The regional forecast highlights Asia Pacific’s sustained leadership, while North America and Europe capitalize on innovation and regulatory clarity. Latin America and Middle East & Africa present untapped potential, albeit with fragmented market ecosystems.

Competitive Landscape

The Chinese Herbal Pieces and Chinese Herbal Formula Granules market exhibits a moderately consolidated structure, with a balance between regional players and national firms. The competitive landscape is characterized by Chinese Herbal Pieces and Chinese Herbal Formula Granules key players leveraging product differentiation through herbal sourcing quality, granule formulation consistency, and GMP certifications. Pricing strategies vary between premium positioning for branded products and cost-competitive approaches for mass-market segments. Distribution channels remain fragmented, with offline retail dominating but e-commerce adoption rising among mid-tier brands. Regulatory compliance and traditional medicine credentials serve as critical barriers to entry, favoring established manufacturers with vertical integration in raw material supply.

Competitive differentiation hinges on technology-driven quality control, localized herbal sourcing networks, and strategic partnerships with TCM hospitals for clinical validation. Common strategies include vertical integration to secure raw material supply chains and product launches targeting chronic disease management segments. A key challenge is margin pressure from raw material price volatility and stringent regulatory updates. Firms also face rising compliance costs to meet evolving pharmacopoeia standards while balancing affordability for rural markets.

China Traditional Chinese Medicine Co.Limited: regional expansion through hospital partnerships

Tianjin Chase Sun Pharmaceutical Co.,Ltd.: premium pricing for high-purity granule formulations

China Resources Sanjiu: innovation pipeline targeting Western medicine integration

China Shineway: vertical integration in herbal cultivation and processing

Shanghai Pharmaceuticals: OEM tie-ups for cost-efficient granule production

PuraPharm: localized manufacturing hubs in key Chinese medicinal regions

Key Chinese Herbal Pieces and Chinese Herbal Formula Granules Companies19 items

China Traditional Chinese Medicine Co.Limited

Tianjin Chase Sun Pharmaceutical Co.,Ltd.

China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.

China Shineway Pharmaceutical Group Limited

Shanghai Pharmaceuticals Holding Co.,Ltd.

PuraPharm

Jiangxi Baishen Pharmaceutical Co.,Ltd.

Sichuan Neo-green Pharmaceutical Technology Development Co.,Ltd

Yunnan Qidan Pharmaceutical Co.,Ltd

Luzhou Baicaotang Chinese Herbal Pieces Co.,Ltd.

Tong Ren Tang Technologies Co. Ltd.

Sichuan Neautus Traditional Chinese Medicine Co.,Ltd.

Kangmei Pharmaceutical Co.,Ltd.

Zhongzhi Pharmaceutical Group

Chongqing Taiji Industry (Group) Co.,Ltd.

Zhejiang Jolly Pharmaceutical Co.,Ltd.

Lanzhou Foci Pharmaceutical Co.,Ltd.

Xiangxue Pharmaceutical Co.,Ltd.

Jilin Aodong Pharmaceutical Group Co.,Ltd.

Market Ecosystem

The Chinese Herbal Pieces and Chinese Herbal Formula Granules ecosystem spans upstream agricultural inputs and technology, midstream processing and formulation, and downstream distribution to healthcare providers and consumers. Value is generated through herbal cultivation, extraction, and standardization, with control points emerging in regulatory compliance and supply chain integration.

Raw material suppliers — provide certified herbal ingredients and packaging materials

OEM manufacturers — produce standardized herbal pieces and formula granules

Technology providers — supply processing equipment for extraction and drying

Distributors — manage logistics to hospitals, pharmacies, and retail channels

Service providers — conduct quality testing and certification for regulatory compliance

Regulators — enforce pharmacopeia standards and approval protocols

End users — include hospitals, clinics, and direct-to-consumer herbal retailers

Control points are concentrated in regulators and key manufacturers, which dictate standards and product specifications. Dependency risks arise from raw material availability and adherence to value chain analysis-defined compliance frameworks. Switching costs for end users are influenced by brand loyalty and formulation consistency, while regional disparities in regulatory enforcement and consumer preference shape market dynamics.

Recent Industry Insights

The Chinese Herbal Pieces and Chinese Herbal Formula Granules industry trends have been shaped by strategic collaborations and technological advancements over the past 18 months. Key players have prioritized partnerships to enhance R&D capabilities, such as joint ventures between traditional herbal manufacturers and biotech firms to standardize herbal formulations. Regulatory shifts in China, including stricter quality control measures for herbal granules, have driven innovation in production processes, with companies adopting AI-powered analytics to ensure compliance. Consumer demand for ready-to-use formula granules has surged, reflecting a broader trend toward convenience in traditional medicine. Notably, several firms secured significant funding to expand their export footprint, particularly in Southeast Asia and the Middle East, where interest in complementary therapies is rising. Mergers in the sector, such as the acquisition of regional herbal processors by national conglomerates, signal consolidation to strengthen supply chain efficiency. Forward-looking investments in sustainable sourcing and digital health integrations—like mobile apps for personalized herbal recommendations—underscore the industry’s pivot toward tech-driven, consumer-centric solutions.

Analyst Overview

The Chinese Herbal Pieces and Chinese Herbal Formula Granules market outlook remains robust, driven by rising demand for traditional medicine and government-backed healthcare initiatives. Market attractiveness is underscored by strong growth potential in both domestic consumption and international exports, particularly in Asia-Pacific and Western markets. Competitive intensity is moderate, with fragmented players coexisting alongside established manufacturers leveraging R&D and standardization to gain share. The long-term outlook is optimistic, supported by urbanization trends, aging populations, and increasing acceptance of complementary therapies. Innovation is accelerating in processing technologies and product diversification, including ready-to-use granules and personalized herbal formulations. However, demand-supply balance faces pressure from raw material scarcity and seasonal harvesting challenges, necessitating sustainable sourcing strategies. Key risks include stringent regulatory scrutiny, quality control inconsistencies, and competition from synthetic alternatives. Strategic investments in digital traceability and clinical validation are critical for sustaining growth.

12 items

1. Executive Summary

2. Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Competition by Key Manufacturers

9.1. Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Chinese Herbal Pieces and Chinese Herbal Formula Granules: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. China Traditional Chinese Medicine Co.Limited

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Tianjin Chase Sun Pharmaceutical Co.,Ltd.

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. China Shineway Pharmaceutical Group Limited

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Shanghai Pharmaceuticals Holding Co.,Ltd.

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. PuraPharm

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Jiangxi Baishen Pharmaceutical Co.,Ltd.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Sichuan Neo-green Pharmaceutical Technology Development Co.,Ltd

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Yunnan Qidan Pharmaceutical Co.,Ltd

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Luzhou Baicaotang Chinese Herbal Pieces Co.,Ltd.

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Tong Ren Tang Technologies Co. Ltd.

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Sichuan Neautus Traditional Chinese Medicine Co.,Ltd.

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Kangmei Pharmaceutical Co.,Ltd.

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Zhongzhi Pharmaceutical Group

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Chongqing Taiji Industry (Group) Co.,Ltd.

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Zhejiang Jolly Pharmaceutical Co.,Ltd.

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Lanzhou Foci Pharmaceutical Co.,Ltd.

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Xiangxue Pharmaceutical Co.,Ltd.

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Jilin Aodong Pharmaceutical Group Co.,Ltd.

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market

Figure 4: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market: Drivers

Figure 5: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market: Challenges

Figure 6: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market: Trends

Figure 7: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market: Opportunity

Figure 8: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market: Restraint

Figure 9: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Value (USD Million) By Region

Figure 19: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Value (USD Million) By Region

Figure 27: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Share (%) By: Regions (2032)

Figure 28: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Volume (K) By Region

Figure 29: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Value (USD Million) By Region

Figure 37: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Share (%) By: Regions (2032)

Figure 38: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Volume (K) By Region

Figure 39: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

133 items

Table 1: Market Segmentation Analysis

Table 2: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Value (USD Million) By Region

Table 14: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Volume (K) By Region

Table 31: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: China Traditional Chinese Medicine Co.Limited Basic Information And Sales Area

Table 52: China Traditional Chinese Medicine Co.Limited. Products Portfolio

Table 53: Tianjin Chase Sun Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 54: Tianjin Chase Sun Pharmaceutical Co.,Ltd.. Products Portfolio

Table 55: China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 56: China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.. Products Portfolio

Table 57: China Shineway Pharmaceutical Group Limited Basic Information And Sales Area

Table 58: China Shineway Pharmaceutical Group Limited. Products Portfolio

Table 59: Shanghai Pharmaceuticals Holding Co.,Ltd. Basic Information And Sales Area

Table 60: Shanghai Pharmaceuticals Holding Co.,Ltd.. Products Portfolio

Table 61: PuraPharm Basic Information And Sales Area

Table 62: PuraPharm. Products Portfolio

Table 63: Jiangxi Baishen Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 64: Jiangxi Baishen Pharmaceutical Co.,Ltd.. Products Portfolio

Table 65: Sichuan Neo-green Pharmaceutical Technology Development Co.,Ltd Basic Information And Sales Area

Table 66: Sichuan Neo-green Pharmaceutical Technology Development Co.,Ltd. Products Portfolio

Table 67: Yunnan Qidan Pharmaceutical Co.,Ltd Basic Information And Sales Area

Table 68: Yunnan Qidan Pharmaceutical Co.,Ltd. Products Portfolio

Table 69: Luzhou Baicaotang Chinese Herbal Pieces Co.,Ltd. Basic Information And Sales Area

Table 70: Luzhou Baicaotang Chinese Herbal Pieces Co.,Ltd.. Products Portfolio

Table 71: Tong Ren Tang Technologies Co. Ltd. Basic Information And Sales Area

Table 72: Tong Ren Tang Technologies Co. Ltd.. Products Portfolio

Table 73: Sichuan Neautus Traditional Chinese Medicine Co.,Ltd. Basic Information And Sales Area

Table 74: Sichuan Neautus Traditional Chinese Medicine Co.,Ltd.. Products Portfolio

Table 75: Kangmei Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 76: Kangmei Pharmaceutical Co.,Ltd.. Products Portfolio

Table 77: Zhongzhi Pharmaceutical Group Basic Information And Sales Area

Table 78: Zhongzhi Pharmaceutical Group. Products Portfolio

Table 79: Chongqing Taiji Industry (Group) Co.,Ltd. Basic Information And Sales Area

Table 80: Chongqing Taiji Industry (Group) Co.,Ltd.. Products Portfolio

Table 81: Zhejiang Jolly Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 82: Zhejiang Jolly Pharmaceutical Co.,Ltd.. Products Portfolio

Table 83: Lanzhou Foci Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 84: Lanzhou Foci Pharmaceutical Co.,Ltd.. Products Portfolio

Table 85: Xiangxue Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 86: Xiangxue Pharmaceutical Co.,Ltd.. Products Portfolio

Table 87: Jilin Aodong Pharmaceutical Group Co.,Ltd. Basic Information And Sales Area

Table 88: Jilin Aodong Pharmaceutical Group Co.,Ltd.. Products Portfolio

Table 89: Global Market Value (USD Million) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Value (USD Million) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global Market Volume (K) (2025-2032) By Application

Table 94: Global Market Share (%) By Application (2032)

Table 95: Global Market Volume (K) (2025-2032) By Types

Table 96: Global Market Share (%) By Types (2032)

Table 97: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Value (USD Million) By Region

Table 98: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Share (%) By Region (2025-2032)

Table 99: North America Market Value (USD Million) (2025-2032) By Country

Table 100: North America Market Value (USD Million) (2025-2032) By Application

Table 101: North America Market Value (USD Million) (2025-2032) By Types

Table 102: Europe Market Value (USD Million) (2025-2032) By Country

Table 103: Europe Market Value (USD Million) (2025-2032) By Application

Table 104: Europe Market Value (USD Million) (2025-2032) By Types

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 106: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 108: South America Market Value (USD Million) (2025-2032) By Country

Table 109: South America Market Value (USD Million) (2025-2032) By Application

Table 110: South America Market Value (USD Million) (2025-2032) By Types

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 112: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 114: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Volume (K) By Region

Table 115: Global Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Share (%) By Region (2025-2032)

Table 116: North America Market Volume (K) (2025-2032) By Country

Table 117: North America Market Volume (K) (2025-2032) By Application

Table 118: North America Market Volume (K) (2025-2032) By Types

Table 119: Europe Market Volume (K) (2025-2032) By Country

Table 120: Europe Market Volume (K) (2025-2032) By Application

Table 121: Europe Market Volume (K) (2025-2032) By Types

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 123: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 125: South America Market Volume (K) (2025-2032) By Country

Table 126: South America Market Volume (K) (2025-2032) By Application

Table 127: South America Market Volume (K) (2025-2032) By Types

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 129: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 131: Research Programs/Design For This Report

Table 132: Key Data Information From Secondary Sources

Table 133: Key Data Information From Primary Sources

FAQs

1. What is the current Chinese Herbal Pieces and Chinese Herbal Formula Granules market size?

The global market size was valued at USD 1.2 billion in 2023, driven by demand in Asia-Pacific and growing interest in traditional medicine worldwide.

2. What is the expected growth rate of the market?

The market is projected to grow at a CAGR of 6.8% from 2024 to 2030, fueled by increasing health consciousness and R&D advancements.

3. What are the primary growth drivers?

Key drivers include rising consumer preference for natural remedies, government support for traditional medicine, and expanding healthcare infrastructure in emerging markets.

4. What challenges does the market face?

Challenges include stringent regulatory requirements, standardization issues, and competition from synthetic pharmaceuticals.

5. Which regions are leading the market?

Asia-Pacific dominates the market, followed by North America and Europe, with China being the largest contributor due to its historical and cultural heritage in herbal medicine.

6. Who are the top companies in this market?

Leading players include TCM Group, Walgreens, China Resources, and Tong Ren Tang, leveraging brand reputation and extensive distribution networks.

7. What future opportunities exist for this market?

Opportunities lie in product innovation, expanding into wellness-focused retail channels, and targeting aging populations with chronic disease management solutions.

8. How is technology impacting the market?

Technology enhances quality control through AI-driven analytics, improves supply chain efficiency, and supports digital health integration for personalized herbal prescriptions.

9. What is the regulatory landscape?

Regulations vary globally but increasingly align with WHO and FDA guidelines, emphasizing safety, quality, and standardized production processes.

10. How will the market evolve by 2030?

By 2030, the market is expected to see a surge in demand for eco-friendly packaging, digital health platforms, and cross-border e-commerce expansion.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Chinese Herbal Pieces and Chinese Herbal Formula Granules Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.50 billion
Revenue forecast in 2033	26.41 billion
Growth rate	CAGR of 9.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	China Traditional Chinese Medicine Co.Limited; Tianjin Chase Sun Pharmaceutical Co.,Ltd.; China Resources Sanjiu Medical&Pharmaceutical Co.,Ltd.; China Shineway Pharmaceutical Group Limited; Shanghai Pharmaceuticals Holding Co.,Ltd.; PuraPharm; Jiangxi Baishen Pharmaceutical Co.,Ltd.; Sichuan Neo-green Pharmaceutical Technology Development Co.,Ltd; Yunnan Qidan Pharmaceutical Co.,Ltd; Luzhou Baicaotang Chinese Herbal Pieces Co.,Ltd.; Tong Ren Tang Technologies Co. Ltd.; Sichuan Neautus Traditional Chinese Medicine Co.,Ltd.; Kangmei Pharmaceutical Co.,Ltd.; Zhongzhi Pharmaceutical Group; Chongqing Taiji Industry (Group) Co.,Ltd.; Zhejiang Jolly Pharmaceutical Co.,Ltd.; Lanzhou Foci Pharmaceutical Co.,Ltd.; Xiangxue Pharmaceutical Co.,Ltd.; Jilin Aodong Pharmaceutical Group Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options